Gastroparesis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• GLP-1 3
• GIP 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 113 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Disposable Endoscope Platform in Third Space Endoscopic Procedures

  NCT06738628· Baylor College of Medicine· Updated 1 Oct 2026

  “The study was closed by the investigator prior to enrollment of any participants. The IRB has been notified and the study is closed.”Registry text, quoted unchanged. Source

• Terminated

  Rifaximin in Patients With Diabetic Gastroparesis

  NCT04254549· Mayo Clinic· Updated 22 Jun 2026

  “Sponsor discontinued placebo. Unable to meet enrollment goals.”Registry text, quoted unchanged. Source

• Terminated

  Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis

  NCT04287647· Northwestern University· Updated 1 Jun 2026

  “Excessive stent migration.”Registry text, quoted unchanged. Source

• Terminated

  A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

  NCT04869670· Mayo Clinic· Updated 22 May 2026

  “Inability to recruit patients for Sham controlled study; therefore, the study was terminated”Registry text, quoted unchanged. Source

• Suspended

  A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis

  NCT05079568· Mayo Clinic· Updated 6 Mar 2026

  “Pending funding”Registry text, quoted unchanged. Source

• Withdrawn

  Use of EndoFLIP and Manometry Prior to G-POEM

  NCT04844190· Northwestern University· Updated 22 Sept 2025

  “Unable to complete study procedures due to staffing issues.”Registry text, quoted unchanged. Source

• Terminated

  GI-Challenge Study for Gastroparesis Patients and Healthy Controls

  NCT03896126· Stanford University· Updated 4 Sept 2025

  “Study was stopped due to technical issues with the ANSAR equipment, lack of research personnel caused by COVID-19 restrictions imposed at our site, and recent departure of the PI and study chair from our research institute.”Registry text, quoted unchanged. Source

• Withdrawn

  Comparison of Outcomes for Single vs Double Pyloromyotomy for Gastroparesis Randomized Controlled Trial

  NCT06173336· University of Arkansas· Updated 25 Jun 2025

  “Study never started”Registry text, quoted unchanged. Source

• Withdrawn

  Cereset Research For Chronic Nausea

  NCT05229107· Wake Forest University Health Sciences· Updated 12 Mar 2024

  “Both Co-PI, Dr. Ken Koch and Dr. Rajeski, have both left the institution, so we have not been able to receive referrals since their departure.”Registry text, quoted unchanged. Source

• Withdrawn

  Nutritional Drink in Gastroparesis

  NCT03500354· Johns Hopkins University· Updated 13 Mar 2023

  “PI moved to another institution and closed the study.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• 24-hour Clear Liquid Diet vs. Standard Fasting for Upper Gastrointestinal Endoscopy in Patients Taking Agonists of the GLP-1 Receptor

  NCT07929233· Portuguese Oncology Institute, Coimbra· Source

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Source

• Stomach-Partitioning Versus Conventional Gastrojejunostomy for Malignant Gastric Outlet Obstruction: A Multicenter Randomized Controlled Trial

  NCT07561073· Guangxi Medical University· Source

• Acupuncture for Postoperative Gastric Emptying Delay

  NCT07505927· Qilu Hospital of Shandong University· Source

• Gastroparesis Registry 4

  NCT05846802· Johns Hopkins Bloomberg School of Public Health· Source

• Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms

  NCT04661215· Johns Hopkins Bloomberg School of Public Health· Source

• GpCRC Pediatric Gastroparesis Registry 2

  NCT05981300· Johns Hopkins Bloomberg School of Public Health· Source

• Intra-abdominal Hypertension and Abdominal Compartment Syndrome in Patients After Pancreatic Procedures.

  NCT06672601· Charles University, Czech Republic· Source

• Pediatric Gastroparesis Registry

  NCT03680820· Johns Hopkins Bloomberg School of Public Health· Source

• Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

  NCT06038734· University of North Carolina, Chapel Hill· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Whole Genome Sequencing 1
• Immunohistochemistry 1
• Magnetic Resonance Imaging 2
• Cohort Studies 11

• Revisional surgery for delayed gastric conduit emptying after esophagectomy: the RESTORANT project.

  Dis Esophagus, Sept 2026

• Preoperative ultrasound assessment of gastric volume in diabetic patients scheduled for elective surgery: a prospective, observational, comparative cohort study.

  BMC Anesthesiol, Jul 2026

• Rapid Gastric Emptying: Insights from a Large Cohort Study on a Controversial Disorder.

  Dig Dis Sci, Jul 2026

• Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.

  Diabetes Obes Metab, Jun 2026

• Gastric POCUS as a Perioperative Risk Assessment Tool in Hospitalized Patients Receiving Methadone for Opioid Use Disorder: A Pilot Study.

  J Ultrasound Med, Apr 2026

• Selecting the Right Patient for Gastric Electrical Stimulation: Using Blinded Temporary Stimulation Trials in Children and Adolescents.

  Neuromodulation, Jan 2026

• The Impact of Cannabis Use in Gastroparesis: A Propensity-Matched Analysis of 41,374 Gastroparesis Patients.

  Am J Gastroenterol, Apr 2025

• In reply: Comment on: Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.

  Can J Anaesth, Jun 2024

• Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.

  Can J Anaesth, Mar 2024

• Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit.

  Dig Dis Sci, Nov 2019

See which targets of this disease your abstract mentions, and go to the people working on them.